Moss Beach, CA, United States of America

Brian P Stupi

USPTO Granted Patents = 4 


Average Co-Inventor Count = 8.0

ph-index = 4

Forward Citations = 68(Granted Patents)


Company Filing History:


Years Active: 2006-2008

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Brian P. Stupi: Innovator in Inflammatory Disease Treatment

Introduction

Brian P. Stupi is a notable inventor based in Moss Beach, CA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target inflammatory diseases. With a total of 4 patents, his work has the potential to impact the treatment of various serious health conditions.

Latest Patents

Stupi's latest patents focus on compounds that bind to α-integrins, specifically VLA-4. These compounds are designed to inhibit leukocyte adhesion, which is crucial in the treatment of inflammatory diseases. The applications of these compounds extend to conditions such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis, and myocardial ischemia. Additionally, they can be utilized for treating inflammatory brain diseases like multiple sclerosis.

Career Highlights

Throughout his career, Brian P. Stupi has worked with prominent companies in the pharmaceutical industry, including Elan Pharmaceuticals, Inc. and Wyeth. His experience in these organizations has contributed to his expertise in developing innovative treatments for complex diseases.

Collaborations

Stupi has collaborated with notable professionals in his field, including Andrei William Konradi and Christopher Michael Semko. These partnerships have likely enhanced his research and development efforts.

Conclusion

Brian P. Stupi's work in developing compounds for the treatment of inflammatory diseases showcases his innovative spirit and dedication to improving patient outcomes. His contributions to medicinal chemistry are significant and continue to influence the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…